[1]
C. Meier, “Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)”, Swiss Med Wkly, vol. 147, no. 3334, p. w14484, Aug. 2017.